M. RAVID, M.D.; M. ROBSON, M.R.C.P.; I. KEDAR (KEIZMAN), M.D.
The natural clinical course of four patients with systemic amyloidosis was favourably altered by continuous colchicine therapy. One patient had primary amyloidosis, and the other three suffered from amyloidosis of familial Mediterranean fever. All had a nephrotic syndrome, and one showed features of intestinal malabsorption. The institution of colchicine therapy was followed by a gradual remission of the nephrotic syndrome, a rise of serum albumin to normal values, a slight improvement of renal function, and regression of the intestinal malabsorption. This pattern has remained steady during an observation period of 30 months.
RAVID M, ROBSON M, KEDAR (KEIZMAN) I. Prolonged Colchicine Treatment in Four Patients with Amyloidosis. Ann Intern Med. ;87:568–570. doi: 10.7326/0003-4819-87-5-568
Download citation file:
Published: Ann Intern Med. 1977;87(5):568-570.
Autoimmune Kidney Disease, Celiac Disease and Malabsorption, Gastroenterology/Hepatology, Hospital Medicine, Nephrology.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use